Skip to Content
Merck
CN
All Photos(3)

Key Documents

View All Documentation

453064

Sigma-Aldrich

2-Bromo-N,N-diethylethylamine hydrobromide

98%

Sign Into View Organizational & Contract Pricing
All Photos(3)

About This Item

Linear Formula:
(C2H5)2NCH2CH2Br·HBr
CAS Number:
1069-72-3
Molecular Weight:
261.00
EC Number:
213-962-3
MDL number:
MFCD00040376
UNSPSC Code:
12352100
PubChem Substance ID:
24868558
NACRES:
NA.22

Assay

98%

form

solid

mp

211-215 °C (dec.) (lit.)

functional group

amine
bromo

SMILES string

Br.CCN(CC)CCBr

InChI

1S/C6H14BrN.BrH/c1-3-8(4-2)6-5-7;/h3-6H2,1-2H3;1H

InChI key

HLMHCDKXKXBKQK-UHFFFAOYSA-N

Pictograms

Skull and crossbonesCorrosion
GHS06,GHS05

Signal Word

Danger

Hazard Statements

H300,H315,H318,H335

Hazard Classifications

Acute Tox. 2 Oral - Eye Dam. 1 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKBF9173
MKBF9173V
03512MH
06908KE
03917KO

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Luca Boselli et al.
European journal of medicinal chemistry, 85, 87-94 (2014-08-01)
New gold(I) complexes containing two 1-[2-(diethylamino)ethyl]imidazolydene ligands have been synthesized and characterized. The X-ray structures of two key compounds are presented. All complexes have been tested for their antiproliferative activities in prostate cancer cell line PC-3. Lipophilicity (Log P) has
Vanessa Lopes-Rodrigues et al.
Bioorganic & medicinal chemistry, 25(2), 581-596 (2016-12-03)
Cancer multidrug resistance (MDR) is a major limitation to the success of cancer treatment and is highly associated with the overexpression of drug efflux pumps such as P-glycoprotein (P-gp). In order to achieve more effective chemotherapeutic treatments, it is important

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service